HOW IS OLEPTRO DOING??

Quote
Anonymous said:
Me and eight other reps are going to turn in our resignation because Psychologists and Psychiatrists are refusing to meet with us once we uter the words Labopharm and James Howard Tripp.Apparently this company and this ceo have a very bad reputation on the street and when I say reputation by that I mean their products are Generic.This is my first and last post since the 8 other reps and I will be leaving in the next week or so.Beware from this company and its products.
Click to expand...



PUHHHLEEZE--psychologists don't meet with "us" anyway. What a lame response.
 


















Anonymous said:
Me and eight other reps are going to turn in our resignation because Psychologists and Psychiatrists are refusing to meet with us once we uter the words Labopharm and James Howard Tripp.Apparently this company and this ceo have a very bad reputation on the street and when I say reputation by that I mean their products are Generic.This is my first and last post since the 8 other reps and I will be leaving in the next week or so.Beware from this company and its products.
Click to expand...

ceo Howard Tripp will fail the product Oleptro. No experience and his has failed before with his company. The chance for success must demand change in ceo.
 






Anonymous said:
IMS numbers are in and they're dismal. This is going to get ugly fast now I suspect. Should I put this contract on my resume or just ignore it altogether? Thoughts?
Click to expand...

Hmmmm..... thoughts..... Stock price is rocking. 90 cents a share. 10 cents above the 52-week low. Buy, Buy, Buy!!!! ..... But it is falling..... Sell, Sell, Sell!!!!! Call Gorden Gecko, he'll know what to do. Maybe Bud Fox has some insider trading tips.

So Long, Suckers!!
 




































Anonymous said:
Hmmmm--mmm

Maybe the Novaquest Lilly contract people should have rolled over on this contract. We had proven sales results.
Click to expand...

I agree. Cymbalta was one of the fastest pharmaceuticals to reach "blockbuster" status. Probably one of the best sales teams that Quintiles had put together...... then, they blew it. Oh well, Quintiles. You win some, you lose some.
 






Early results are not even a fly-speck. Forrest and Pfizer don't have the product listed on their IMS reports (it's assigned to the "generic" column) and their Psych-specialty forces don't care about the product at all. Two hours of Lexapro revenue will equal what this product does in a year - it's a yawner.
 






Anonymous said:
Early results are not even a fly-speck. Forrest and Pfizer don't have the product listed on their IMS reports (it's assigned to the "generic" column) and their Psych-specialty forces don't care about the product at all. Two hours of Lexapro revenue will equal what this product does in a year - it's a yawner.
Click to expand...

Is this the truth? Is it really not doing well? Will the contract end early?
 


















They are crazy to think you can launch a new product and hit the kind of goals they are looking for. No product does that. If you are patient and work hard you can get a product going in about 9 months to a year, not month 1. Even Cymbalta did not begin to hit its numbers until it had been out for about a year and a half in the North East. You can ask for anything you want. The sky is the limit; but that doesn't mean that you will get it. I myself would like 2 million dollars tomorrow. Do you think I will get it?
 






Think we're OK for now, but goal is unrealistic. If that's the number Labo needs to survive then we could be in trouble down the road. I'd like to talk about this with my DM, but he's too much of a dick to even bring it up.
 












Anonymous said:
They are crazy to think you can launch a new product and hit the kind of goals they are looking for. No product does that. If you are patient and work hard you can get a product going in about 9 months to a year, not month 1. Even Cymbalta did not begin to hit its numbers until it had been out for about a year and a half in the North East. You can ask for anything you want. The sky is the limit; but that doesn't mean that you will get it. I myself would like 2 million dollars tomorrow. Do you think I will get it?
Click to expand...

send me an email labopharm@hotmail.com
 






This is not Cymbalta in any shape or form. Oleptro is the re-packaging of a molecule that's been on the market for 30 years and has steadily seen declining share due to other TCA's, generic formulations and the introduction of SSRI's and SNRI's. Refering to Cymbalta performance as an analogy is mistaken. This product isn't going anywhere now nor in the future.
 






Top Bottom
Back
Quote